) [153]. This process is at the moment not scalable mainly because it relies on high-priced startup substrates which can be employed to supply psilocybin in cheaper chemical synthesis methodologies. A methodology for de novo manufacture of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,To reiterate, the effects of magic mushrooms